Form D · Biotechnology
NEUROLOGICA CORP
Danvers, MA · CIK 0001362747
Offering snapshot reported Jan 10, 2012 · SEC filing
- Reported sold
- $12M Offering amount: $12M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 29, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 10, 2012 | Initial | $12,000,000 | No comparison | 3 | SEC filing |
| Nov 24, 2008 | Initial | $5,000,000 | No comparison | Not reported | SEC filing |
| Oct 1, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 8, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-171504
Source: Form D, filed Jan 10, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric M. Bailey | Director, Executive |
| Jeffrey Cohen | Executive |
| Bernard M. Gordon | Director |
| Raymond Stata | Director |
| Andrew Tybinkowski | Director |
| Nicholas Zervas | Director |
| Nick Zervas | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
14 Electronics Ave
Danvers, MA, 01923-1011
Danvers, MA, 01923-1011